Alex Soltermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alex Soltermann has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
- Holger Moch
Department of Pathology and Molecular Pathology, University of Zurich and University Hospital, Zurich, Switzerland
2 shared publications - Walter Weder
Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
2 shared publications A. V. Borgarello
Univ. Nac. de Rio Cuarto, Rio Cuarto, Argentina
1 shared publicationAbhinandan Pattanayak
1 shared publication- Adam Ertel
Sidney Kimmel Cancer Center Thomas Jefferson University, Philadelphia, Pennsylvania
1 shared publication - Agnieszka K. Witkiewicz
Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, USA
1 shared publication
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy
- Open Access
- 3 November 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors
Dysfunctional DNA repair with subsequent genome instability and high mutational burden represents a major hallmark of cancer. In established malignant tumors, increased DNA repair capacity mediates resistance to DNA-damaging therapeutics, including cytotoxic drugs, radiotherapy, and selected small molecules including inhibitors of poly (ADP-ribose) polymerase (PARP), Ataxia Telangiectasia Mutated (ATM), ataxia telangiectasia and Rad3-related protein (ATR), and Wee1 kinase (Wee1). In addition, DNA repair deficiency is not only associated with sensitivity to selected anticancer drugs, but also with increased mutagenicity and increased neoantigen load on tumor cells, resulting in increased immunogenicity and improved response to CTLA4- or PD-(L)1 targeting monoclonal antibodies. DNA damage response (DDR) is composed of complex signalling pathways, including the sensing of the DNA damage, signal transduction, cellular response pathways to DNA damage, and activation of DNA repair. DNA double strand breaks (DSBs) are the most dangerous form of DNA damage. Tumor cells are characterised by frequent accumulation of DSBs caused by either endogenous replication stress or the impact of cancer treatment, most prominently chemotherapy and radiotherapy. Therefore, response of cancer cells to DSBs represents a crucial mechanism for how tumors respond to systemic treatment or radiotherapy, and how resistance develops. Ample clinical evidence supports the importance of DDR associated kinases as predictive and prognostic biomarkers in cancer patients. The ATM-CHK2 and ATR-CHK1-WEE1 pathways initiate DNA DSB repair. In the current review, we focus on major DDR associated kinases including ATM, ATR, CHK1, CHK2, and WEE1, and discuss their potential prognostic and predictive value in solid malignancies.
- 3 November 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Open AccessPredictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors
Dysfunctional DNA repair with subsequent genome instability and high mutational burden represents a major hallmark of cancer. In established malignant tumors, increased DNA repair capacity mediates resistance to DNA-damaging therapeutics, including cytotoxic drugs, radiotherapy, and selected small molecules including inhibitors of poly (ADP-ribose) polymerase (PARP), Ataxia Telangiectasia Mutated (ATM), ataxia telangiectasia and Rad3-related protein (ATR), and Wee1 kinase (Wee1). In addition, DNA repair deficiency is not only associated with sensitivity to selected anticancer drugs, but also with increased mutagenicity and increased neoantigen load on tumor cells, resulting in increased immunogenicity and improved response to CTLA4- or PD-(L)1 targeting monoclonal antibodies. DNA damage response (DDR) is composed of complex signalling pathways, including the sensing of the DNA damage, signal transduction, cellular response pathways to DNA damage, and activation of DNA repair. DNA double strand breaks (DSBs) are the most dangerous form of DNA damage. Tumor cells are characterised by frequent accumulation of DSBs caused by either endogenous replication stress or the impact of cancer treatment, most prominently chemotherapy and radiotherapy. Therefore, response of cancer cells to DSBs represents a crucial mechanism for how tumors respond to systemic treatment or radiotherapy, and how resistance develops. Ample clinical evidence supports the importance of DDR associated kinases as predictive and prognostic biomarkers in cancer patients. The ATM-CHK2 and ATR-CHK1-WEE1 pathways initiate DNA DSB repair. In the current review, we focus on major DDR associated kinases including ATM, ATR, CHK1, CHK2, and WEE1, and discuss their potential prognostic and predictive value in solid malignancies.
- 1 October 2019
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (10) , S965
EP1.03-33 CD26/DPP4 as a Novel Prognostic Marker for Lung Adenocarcinoma
- 1 October 2019
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (10) , S965
EP1.03-33 CD26/DPP4 as a Novel Prognostic Marker for Lung Adenocarcinoma
- Open Access
- 16 February 2018
- Published by Elsevier in Pathology - Research and Practice
- Vol. 214 (4) , 572-578
Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma—a single center retrospective study
- 16 February 2018
- Published by Elsevier in Pathology - Research and Practice
- Vol. 214 (4) , 572-578
Open AccessTargeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma—a single center retrospective study
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA583
microRNA profile in COPD patients with and without pulmonary hypertension
Introduction: Pulmonary hypertension is a common complication in patients with severe chronic obstructive pulmonary disease (COPD) but the pathogenesis of its development is not completely understood. MicroRNAs (miRNAs) are small, non-coding gene regulators that have been associated with the pathogenesis of pulmonary hypertension. Here we investigated the signature from miRNAs in lung tissue slides from patients with end-stage COPD with and without elevated pulmonary pressure. Methods: Paraffin-embedded lung tissue specimens from COPD patients undergoing lung volume reduction surgery (LVRS) or lung transplantation were used. Pulmonary hemodynamics was invasively assessed in all patients before surgery. miRNA isolation was performed using the recoverall total nucleic acid isolation kit (Ambion ®) and quantified by qPCR. Results: 11 miRNAs previously associated with the pathogenesis of pulmonary hypertension were analysed. Significantly decreased expression levels of miR-125a (-0.54±0.33 vs 0.01±0.65, pConclusion: This is the first report on the miRNA profile of COPD patients with and without pulmonary hypertension showing that most miRNAs are downregulated in patients with PH-COPD. Further studies are needed to answer the question whether this miRNA profile can be employed as predictor for the presence of an elevated pulmonary pressure in COPD patients.
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA583
microRNA profile in COPD patients with and without pulmonary hypertension
Introduction: Pulmonary hypertension is a common complication in patients with severe chronic obstructive pulmonary disease (COPD) but the pathogenesis of its development is not completely understood. MicroRNAs (miRNAs) are small, non-coding gene regulators that have been associated with the pathogenesis of pulmonary hypertension. Here we investigated the signature from miRNAs in lung tissue slides from patients with end-stage COPD with and without elevated pulmonary pressure. Methods: Paraffin-embedded lung tissue specimens from COPD patients undergoing lung volume reduction surgery (LVRS) or lung transplantation were used. Pulmonary hemodynamics was invasively assessed in all patients before surgery. miRNA isolation was performed using the recoverall total nucleic acid isolation kit (Ambion ®) and quantified by qPCR. Results: 11 miRNAs previously associated with the pathogenesis of pulmonary hypertension were analysed. Significantly decreased expression levels of miR-125a (-0.54±0.33 vs 0.01±0.65, pConclusion: This is the first report on the miRNA profile of COPD patients with and without pulmonary hypertension showing that most miRNAs are downregulated in patients with PH-COPD. Further studies are needed to answer the question whether this miRNA profile can be employed as predictor for the presence of an elevated pulmonary pressure in COPD patients.
- Open Access
- 31 January 2014
- Published by EdiUNS - Editorial de la Universidad Nacional del Sur in Latin American Applied Research - An international journal
- Vol. 44 (1) , 25-30
USE OF A FREE RADICAL SCAVENGING METHOD ON EXTRACTS OBTAINED BY MOLECULAR DISTILLATION FROM OREGANO ESSENTIAL OIL
There is evidence that oregano essential oil has a significant antioxidant effect on the process of lipid oxidation. In order to obtain fractions enriched in antioxidant properties, oregano essential oil samples were processed by molecular distillation. Molecular distillation experiments were done in two groups of tests, using an evaporating temperature between 22 and 30 ºC. Pressure was varied between 0.7 and 53 mbar. Antioxidant activity, specifically radical scavenging capacity, was analyzed in the essential oil and the distillates and residues obtained by a free radical scavenging method, using DPPH* (2,2-diphenyl-1picrylhydrazyl). The results obtained allowed to conclude that the free radical scavenging capacity was increased in the residue fractions obtained by molecular distillation. These fractions were concentrated in thymol. The IC50 values of the residues were similar to the synthetic antioxidant BHT, suggesting that fractions concentrated in oxygen derivatives obtained by molecular distillation could be used in the food industry to retard lipid degradation.
- 31 January 2014
- Published by EdiUNS - Editorial de la Universidad Nacional del Sur in Latin American Applied Research - An international journal
- Vol. 44 (1) , 25-30
Open AccessUSE OF A FREE RADICAL SCAVENGING METHOD ON EXTRACTS OBTAINED BY MOLECULAR DISTILLATION FROM OREGANO ESSENTIAL OIL
There is evidence that oregano essential oil has a significant antioxidant effect on the process of lipid oxidation. In order to obtain fractions enriched in antioxidant properties, oregano essential oil samples were processed by molecular distillation. Molecular distillation experiments were done in two groups of tests, using an evaporating temperature between 22 and 30 ºC. Pressure was varied between 0.7 and 53 mbar. Antioxidant activity, specifically radical scavenging capacity, was analyzed in the essential oil and the distillates and residues obtained by a free radical scavenging method, using DPPH* (2,2-diphenyl-1picrylhydrazyl). The results obtained allowed to conclude that the free radical scavenging capacity was increased in the residue fractions obtained by molecular distillation. These fractions were concentrated in thymol. The IC50 values of the residues were similar to the synthetic antioxidant BHT, suggesting that fractions concentrated in oxygen derivatives obtained by molecular distillation could be used in the food industry to retard lipid degradation.
- Open Access
- 1 September 2011
- Published by Elsevier in The American Journal of Pathology
- Vol. 179 (3) , A5-A9
Table of Contents
- 1 September 2011
- Published by Elsevier in The American Journal of Pathology
- Vol. 179 (3) , A5-A9
Open AccessTable of Contents
- 1 June 1999
- Published by Elsevier in Experimental Cell Research
- Vol. 249 (2) , 308-319
The Cytochrome b5 Tail Anchors and Stabilizes Subdomains of Human DNA Topoisomerase IIα in the Cytoplasm of Retrovirally Infected Mammalian Cells
- 1 June 1999
- Published by Elsevier in Experimental Cell Research
- Vol. 249 (2) , 308-319
The Cytochrome b5 Tail Anchors and Stabilizes Subdomains of Human DNA Topoisomerase IIα in the Cytoplasm of Retrovirally Infected Mammalian Cells